Advances in Gluten Hypersensitivity: Novel Dietary-Based Therapeutics in Research and Development
Open Access
- 16 April 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (8) , 4399
Abstract
Gluten hypersensitivity is characterized by the production of IgE antibodies against specific wheat proteins (allergens) and a myriad of clinical allergic symptoms including life-threatening anaphylaxis. Currently, the only recommended treatment for gluten hypersensitivity is the complete avoidance of gluten. There have been extensive efforts to develop dietary-based novel therapeutics for combating this disorder. There were four objectives for this study: (i) to compile the current understanding of the mechanism of gluten hypersensitivity; (ii) to critically evaluate the outcome from preclinical testing of novel therapeutics in animal models; (iii) to determine the potential of novel dietary-based therapeutic approaches under development in humans; and (iv) to synthesize the outcomes from these studies and identify the gaps in research to inform future translational research. We used Google Scholar and PubMed databases with appropriate keywords to retrieve published papers. All material was thoroughly checked to obtain the relevant data to address the objectives. Our findings collectively demonstrate that there are at least five promising dietary-based therapeutic approaches for mitigating gluten hypersensitivity in development. Of these, two have advanced to a limited human clinical trial, and the others are at the preclinical testing level. Further translational research is expected to offer novel dietary-based therapeutic options for patients with gluten hypersensitivity in the future.Keywords
Funding Information
- The United States Department of Agriculture (USDA) (MICL02486, MICL02796, 1012322, MICL01699, 2018-67017-27876 (MICL05103))
- Hatch Project (MICL02486, MICL02796, 1012322, MICL01699, 2018-67017-27876 (MICL05103))
- Agricultural and Food Research Initiative Competitive Program (MICL02486, MICL02796, 1012322, MICL01699, 2018-67017-27876 (MICL05103))
- Michigan State University (MICL02486, MICL02796, 1012322, MICL01699, 2018-67017-27876 (MICL05103))
This publication has 81 references indexed in Scilit:
- Wheat α-gliadin and high-molecular-weight glutenin subunit accumulate in different storage compartments of transgenic soybean seedTransgenic Research, 2021
- Genome-wide association study reveals an association between the HLA-DPB1∗02:01:02 allele and wheat-dependent exercise-induced anaphylaxisThe American Journal of Human Genetics, 2021
- Evaluation of the allergenicity of ω5-gliadin-deficient Hokushin wheat (1BS-18) in a wheat allergy rat modelBiochemistry and Biophysics Reports, 2019
- Wheat-induced food allergy in childhood: ancient grains seem no way outEuropean Journal of Nutrition, 2019
- Dynamics of microbial community during the extremely long‐term fermentation process of a traditional soy sauceJournal of the Science of Food and Agriculture, 2017
- Characterization of a hypoallergenic wheat line lacking ω-5 gliadinAllergology International, 2016
- Profiling of dynamic changes in the microbial community during the soy sauce fermentation processApplied Microbiology and Biotechnology, 2013
- Development and characteristics of ω-gliadin-free wheat genotypesEuphytica, 2013
- Effect of Toll-like receptor 4 gene polymorphisms on work-related respiratory symptoms and sensitization to wheat flour in bakery workersAnnals of Allergy, Asthma & Immunology, 2011
- Expression of epitope-tagged LMW glutenin subunits in the starchy endosperm of transgenic wheat and their incorporation into glutenin polymersTheoretical and Applied Genetics, 2003